Literature DB >> 9757918

Applications of thrombolytic therapy.

N Curzen1, R Haque, A Timmis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9757918     DOI： 10.1007/s001340050663

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   41.787


× No keyword cloud information.
  80 in total

Review 1.  The GUSTO trial and the open artery theory.

Authors:  R M Califf
Journal:  Eur Heart J       Date:  1997-12       Impact factor: 29.983

2.  A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.

Authors: 
Journal:  N Engl J Med       Date:  1996-09-12       Impact factor: 91.245

3.  Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.

Authors:  K L Neuhaus; W Feuerer; S Jeep-Tebbe; W Niederer; A Vogt; U Tebbe
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

4.  Pulmonary embolectomy: review of a 15-year experience and role in the age of thrombolytic therapy.

Authors:  H C Doerge; F A Schoendube; H Loeser; M Walter; B J Messmer
Journal:  Eur J Cardiothorac Surg       Date:  1996       Impact factor: 4.191

5.  Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

6.  Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

Review 7.  Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-01       Impact factor: 29.983

8.  A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.

Authors:  C P Cannon; C H McCabe; T D Henry; M J Schweiger; R S Gibson; H S Mueller; R C Becker; N S Kleiman; J M Haugland; J L Anderson
Journal:  J Am Coll Cardiol       Date:  1994-04       Impact factor: 24.094

9.  Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.

Authors:  C Bode; R W Smalling; G Berg; C Burnett; G Lorch; J M Kalbfleisch; R Chernoff; L G Christie; R L Feldman; A A Seals; W D Weaver
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction.

Authors:  D G Mathey; F H Sheehan; J Schofer; H T Dodge
Journal:  J Am Coll Cardiol       Date:  1985-09       Impact factor: 24.094
View more
  3 in total

1.  Thrombolysis with streptokinase during cardiopulmonary resuscitation: a single center experience and review of the literature.

Authors:  Farid Aliyev; Mohammed Habeb; Erhan Babalik; Bilgehan Karadag
Journal:  J Thromb Thrombolysis       Date:  2005-12       Impact factor: 2.300

Review 2.  Safety of thrombolysis during cardiopulmonary resuscitation.

Authors:  Fabian Spöhr; Bernd W Böttiger
Journal:  Drug Saf       Date:  2003       Impact factor: 5.228

3.  Percutaneous Coronary Intervention After Return of Spontaneous Circulation Reduces the In-Hospital Mortality in Patients with Acute Myocardial Infarction Complicated by Cardiac Arrest.

Authors:  Jingcong Zhang; Haixia Xiong; Jie Chen; Qiuping Zou; Xiaoxing Liao; Yujie Li; Chunlin Hu
Journal:  Int J Gen Med       Date:  2021-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.